TRANSPLANTATION IN PATIENTS WITH T-CELL REACTIVITY TO DONOR

被引：0
|
作者：
FALK, JA
NICHOLSON, J
HARDING, M
CARDELLA, CJ
机构：
[1] TORONTO WESTERN HOSP, TISSUE TYPING LAB, TORONTO M5T 2S8, ONTARIO, CANADA
[2] TORONTO WESTERN HOSP, DIV NEPHROL, TORONTO M5T 2S8, ONTARIO, CANADA
来源：
HUMAN IMMUNOLOGY | 1982年 / 5卷 / 02期
关键词：
D O I：
10.1016/0198-8859(82)90076-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [41] More on donor-derived T-cell leukemia after bone marrow transplantation
    Focosi, D
    Petrini, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02): : 212 - 213
  • [42] ASSESSMENT OF DONOR-SPECIFIC ALLOREACTIVITY AND REGULATORY T-CELL FREQUENCY - SUITABILITY IN LIVING DONOR KIDNEY TRANSPLANTATION?
    Vondran, F.
    Timrott, K.
    Tross, J.
    Kollrich, S.
    Gwinner, W.
    Lehner, F.
    Klempnauer, J.
    Becker, T.
    Schwinzer, R.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 31 - 31
  • [43] ANALYSIS OF DUAL REACTIVITY OF T-CELL CLONES AND HYBRIDOMAS BY MAB TO THE T-CELL RECEPTOR
    KANAGAWA, O
    NICOLAS, JF
    GLASEBROOK, AL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 226 - 226
  • [44] Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation
    Le, Robert Quan
    Melenhorst, J. Joseph
    Battiwalla, Minoo
    Hill, Brenna
    Memon, Sarfraz
    Savani, Bipin N.
    Shenoy, Aarthi
    Hensel, Nancy F.
    Koklanaris, Eleftheria K.
    Keyvanfar, Keyvan
    Hakim, Frances T.
    Douek, Daniel C.
    Barrett, A. John
    BLOOD, 2011, 117 (19) : 5250 - 5256
  • [45] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [46] T-CELL DONOR REGISTRY FOR THIRD PARTY ADOPTIVE IMMUNOTHERAPY IN HEMATOPOIETIC CELL AND SOLID ORGAN TRANSPLANTATION
    Maecker-Kolhoff, B.
    Tischer, S.
    Sukdolak, C.
    Bunse, C.
    Figuieiredo, C.
    Immenschuh, S.
    Goudeva, L.
    Heuft, H. -G.
    Blasczyk, R.
    Eiz-Vesper, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S82 - S82
  • [47] Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation
    Petersen, Scott M.
    Gendelman, Mariya
    Murphy, Kathleen M.
    Torbenson, Michael
    Jones, Richard J.
    Althaus, Janyne E.
    Stetten, Gail
    Bird, Chris
    Blakemore, Karin J.
    FETAL DIAGNOSIS AND THERAPY, 2007, 22 (03) : 175 - 179
  • [48] FREQUENCY-ANALYSIS OF DONOR-SPECIFIC CYTOTOXIC T-CELL PRECURSORS IN PATIENTS AFTER KIDNEY-TRANSPLANTATION
    ZANKER, B
    KABELITZ, D
    HERZOG, WR
    FRANZ, HE
    WAGNER, H
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2611 - 2613
  • [49] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [50] Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced
    van Besouw, NM
    van der Mast, BJ
    de Kuiper, P
    Gregoor, PJHS
    Vaessen, LMB
    Ijzermans, JNM
    van Gelder, T
    Weimar, W
    TRANSPLANTATION, 2000, 70 (01) : 136 - 143
12345